Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27966044)

Published in Eur Radiol on December 13, 2016

Authors

Dominik Geisel1, Philip Raabe2, Lutz Lüdemann3, Maciej Malinowski4, Martin Stockmann4, Daniel Seehofer4, Johann Pratschke4, Bernd Hamm2, Timm Denecke2

Author Affiliations

1: Department of Diagnostic and Interventional Radiology, Charité Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany. dominik.geisel@charite.de.
2: Department of Diagnostic and Interventional Radiology, Charité Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.
3: Department of Medical Physics, Essen University Hospital, Essen, Germany.
4: Department of General, Visceral and Transplantation Surgery, Charité Campus Virchow-Klinikum, Berlin, Germany.

Articles cited by this

Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16

Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg (2007) 2.96

Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery (2000) 2.55

Portal vein embolization: rationale, technique and future prospects. Br J Surg (2001) 2.41

Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33

Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21

Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg (2009) 2.06

Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg (2011) 1.99

Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg (2010) 1.81

Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg (2006) 1.76

Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos (2010) 1.53

Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol (2012) 1.50

Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med (2011) 1.40

Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg (1996) 1.35

Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg (2012) 1.17

CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE): a new technique for fast time-resolved dynamic 3-dimensional imaging of the abdomen with high spatial resolution. Invest Radiol (2013) 1.03

ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol (2015) 1.03

Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol (2011) 1.01

Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol (2014) 1.00

Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery (2002) 1.00

Evaluation of liver function for hepatic resection. Transplant Proc (2006) 0.99

Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. Br J Radiol (2013) 0.98

Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun (1999) 0.98

Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. J Magn Reson Imaging (2012) 0.93

Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford) (2010) 0.93

MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep (2014) 0.92

Liver resections with or without pedicle clamping. Am J Surg (2001) 0.91

Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry. Eur Radiol (2015) 0.90

Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging (2008) 0.89

Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI. Eur Radiol (2013) 0.83

Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases. Eur J Surg Oncol (2012) 0.82

Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolization. Surg Today (2015) 0.81

Portal Venous Interventions: State of the Art. Radiology (2016) 0.81

Volume change and liver parenchymal signal intensity in Gd-EOB-DTPA-enhanced magnetic resonance imaging after portal vein embolization prior to hepatectomy. Biomed Res Int (2014) 0.79

Imaging-Based Liver Function Tests--Past, Present and Future. Rofo (2015) 0.77

Preoperative estimation of future remnant liver function following portal vein embolization using relative enhancement on gadoxetic acid disodium-enhanced magnetic resonance imaging. Korean J Radiol (2015) 0.77

Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR. Eur J Radiol (2013) 0.77

Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI. Eur Radiol (2015) 0.77